Affinity Asset Advisors, LLC Alkermes Plc. Transaction History
Affinity Asset Advisors, LLC
- $579 Million
- Q3 2024
A detailed history of Affinity Asset Advisors, LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Affinity Asset Advisors, LLC holds 1,000,000 shares of ALKS stock, worth $28.2 Million. This represents 4.84% of its overall portfolio holdings.
Number of Shares
1,000,000
Previous 650,000
53.85%
Holding current value
$28.2 Million
Previous $15.7 Million
78.68%
% of portfolio
4.84%
Previous 2.13%
Shares
5 transactions
Others Institutions Holding ALKS
# of Institutions
360Shares Held
181MCall Options Held
175KPut Options Held
96.6K-
Black Rock Inc. New York, NY29.1MShares$821 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$535 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD13MShares$366 Million0.04% of portfolio
-
Wellington Management Group LLP Boston, MA12.7MShares$357 Million0.06% of portfolio
-
State Street Corp Boston, MA9.19MShares$259 Million0.01% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $4.63B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...